LeonIRosenbergMDBoard Certified

Psychiatry • Cherry Hill, NJ

Child & Adolescent Psychiatry

Adult Psychiatry, Medical Director and Principal Investigator

Join to view full profile

Dr. Rosenberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Rosenberg's full profile

Already have an account?

Office
1 Utah Ave
Cherry Hill, NJ 08002
Phone+1 856-857-9500

Fax+1 856-857-9120
Is this information wrong?

Summary

Dr. Leon Rosenberg is a psychiatrist in Cherry Hill, NJ, where he is the medical director of the Center For Emotional Fitness. He received his medical degree from State University of New York Upstate Medical University and has been in practice 39 years. He specializes in clinical research trials for pharmaceutical agents. He is an adult, child & adolescent psychiatrist. Dr. Jake Rosenberg joined the research division in 2019, joining 866DocLeon and Caryn Rosenberg, MSW

Education & Training

Drexel University College of Medicine/Hahnemann University HospitalFellowship, Child and Adolescent Psychiatry, 1981 - 1983
University of Pennsylvania Health SystemResidency, Psychiatry, 1979 - 1981
Zucker School of Medicine at Hofstra/NorthwellInternship, Transitional Year, 1978 - 1979
SUNY Upstate Medical UniversityClass of 1978
Harvard UniversityAB, Biology, Cum laude, 1970 - 1974

Certifications & Licensure

NJ State Medical License 1983 - 2025
NY State Medical License 2024 - 2025
PA State Medical License 1979 - 2024
CT State Medical License 1992 - 1996
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy Start of enrollment: 2013 Nov 01
Completed
Phase 3
Open-label Safety Study in Adults With ADHD Start of enrollment: 2014 Jun 01
Completed
Phase 3
Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder Start of enrollment: 2015 Jul 27
Completed
Phase 3

Publications & Presentations

PubMed

1 citations
The Use of Brexpiprazole Combined With a Stimulant in Adults With Treatment-Resistant Attention-Deficit/Hyperactivity Disorder.
Frederick W Reimherr, Thomas E Gift, Tammy A Steans, Matthew L Reimherr, Leon I Rosenberg, Melissa Wilson, Barrie K Marchant> ;Journal of Clinical Psychopharmacology. 2022 Aug 18
2 citations
The Ham-D is not Hamilton's Depression Scale.
Leon I Rosenberg> ;Psychopharmacology Bulletin. 2022 May 31